US FDA sends import alert to stop illegal imports of obesity drug ingredients
by Reuters Sep 05, 2025
The U.S. Food and Drug Administration sent an import alert on Friday, aimed at stopping illegal imports of GLP-1 drug ingredients, used for weight loss and diabetes, from entering the domestic market from unverified sources.
The agency said it was aware that some patients are turning to compounded versions of Novo Nordisk's Wegovy and Eli Lilly's Zepbound, which are not approved by it. To protect patients who use compounded drugs, the "green list" alert will include ingredients from facilities the FDA has inspected or evaluated, it said.
The "green list" is part of the FDA's import alert system, identifying firms or products that have resolved compliance concerns and are not subject to automatic detention at the border.
Reuters
Similar Stories
Berlin and UkraineInvest establish first U.S. partner office to expand American investment in Ukraine
View ArticleUS, Australia sign Customs Mutual Assistance Agreement
CMAA enhances trade and security cooperation
View Article
‘China Shock 2.0’: EU primed for action?
View ArticleAfreximbank Africa Trade Report shows Africa can turn geopolitical disruptions into long-term growth opportunity
The report highlights Africa’s continued growth resilience despite significant headwinds occasioned by escalating geopolitical tensions and ensuing economic shifts
View Article
Strait of Hormuz tensions highlight need to put seafarer welfare at the center of contingency planning, says AVS Global Ship Supply
View ArticleFreight forwarders helped make Brexit-era UK–EU trade manageable
As the UK marks ten years since the Brexit referendum, the British International Freight Association (BIFA) is highlighting the vital role played by its members in helping businesses adapt to…
View ArticleGet the most up-to-date trending news!
SubscribeIndustry updates and weekly newsletter direct to your inbox!
Follow us on social media:
